Find uplifting stories about heroes, innovations, and solutions
51 results for "pancreatic cancer"
A daily pill for advanced pancreatic cancer nearly doubled survival time in a major trial, offering new hope for one of the deadliest cancers. Patients lived a median of 13.2 months compared to 6.7 months with standard chemotherapy.
A new pill for pancreatic cancer helped patients live nearly twice as long as standard chemotherapy in a groundbreaking study. The experimental drug could bring hope to one of the deadliest cancers within months.
A breakthrough drug called daraxonrasib has shown it can extend survival in pancreatic cancer patients, one of medicine's toughest challenges. The announcement from Revolution Medicines marks what experts are calling a new era in treating this devastating disease.
A new once-daily pill for pancreatic cancer nearly doubled patient survival in a groundbreaking late-stage study. The experimental drug offers fresh hope for one of the deadliest forms of cancer.
A groundbreaking pill targeting mutations in 90% of pancreatic cancer patients has approximately doubled survival time in clinical trials, offering new hope for one of medicine's toughest challenges. After decades of failed attempts, researchers have finally cracked a target once considered "undruggable."
Ben Sasse was given just months to live when diagnosed with advanced pancreatic cancer in December. A breakthrough drug trial has already extended his life beyond that grim prediction.
A groundbreaking clinical trial is giving hope to thousands facing one of the deadliest cancers. Former Senator Ben Sasse joined the study when doctors gave him just months to live.
Ray Angelone, 57, is running his fourth Boston Marathon, but this time as a Stage 3 pancreatic cancer survivor. After successful treatment at Mass General Hospital, he's returning to the race to support the team that saved his life.
A breakthrough pill for pancreatic cancer almost doubled survival time and cut death risk by 60% in a major trial. Revolution Medicines plans to seek fast-track FDA approval for patients who desperately need new treatment options.
A Michigan woman survived pancreatic cancer not once but twice, and now she's dedicating her life to helping others fight the disease with the same determination that saved her. Her message: be your own advocate.
Scientists at Oregon Health & Science University just cracked a puzzle that's stumped cancer researchers for years: why pancreatic cancer fights off immunotherapy. The discovery could finally give patients new treatment options.
A breakthrough pill for pancreatic cancer, the deadliest major cancer, shows stunning results in trials. Former Senator Ben Sasse's tumors shrank 76% after taking the experimental drug that could become the first targeted treatment for this disease.
Researchers at MD Anderson Cancer Center discovered a protein called DPY30 that helps pancreatic tumors hide from the immune system. Blocking this protein could make stubborn tumors respond to immunotherapy, offering fresh hope for patients with limited treatment options.
When Barry Bloom got pancreatic cancer, he became a research participant and studied his own treatment papers with the same curiosity that defined his 60-year career. The legendary Harvard immunologist who discovered how our immune system remembers past infections died at 88, leaving behind breakthrough discoveries that transformed how we fight diseases like tuberculosis and leprosy.
Stephanie Huppert and Tommy Helmer beat cancer against tough odds and will inspire their community at River Falls' annual Relay For Life event. Their message: early screening saves lives, and no one fights alone.
A Vermont hospital is pioneering a breakthrough treatment that delivers chemotherapy directly to pancreatic tumors while sparing the rest of the body from toxic side effects. The innovative approach could transform care for one of the deadliest cancers.
A Maryland hospital is pioneering a groundbreaking treatment for advanced pancreatic cancer that patients can use at home. For the first time in three decades, there's real hope for a disease that has devastated families.
Scientists at Yale discovered that obesity triggers pancreatic cells to produce a hormone that drives cancer development, opening the door to early detection through simple blood tests. The breakthrough challenges decades of scientific assumptions about how obesity leads to one of the deadliest cancers.
University of Pennsylvania researchers eliminated precancerous pancreatic cells in mice before they became tumors, nearly doubling survival time. It's the first proof that medical intervention can stop pancreatic cancer at its earliest stage.
From Star Trek legends to reality TV favorites, celebrities nationwide are rallying 60,000 people for PanCAN PurpleStride on April 25, aiming to raise $17 million for pancreatic cancer research and patient support. Their personal connections to the disease are turning grief into action and hope into funding for lifesaving breakthroughs.
Showing 20 of 51